Drug touted by Trump to treat COVID-19 linked to higher death risk - study


  • World
  • Friday, 22 May 2020

FILE PHOTO: A pharmacy worker shows pills of hydroxychloroquine used to treat the coronavirus disease (COVID-19) at the CHR Centre Hospitalier Regional de la Citadelle Hospital in Liege, Belgium, April 22, 2020. REUTERS/Yves Herman

(Reuters) - The anti-malarial drug hydroxychloroquine, which U.S. President Donald Trump says he has been taking and has urged others to use, was tied to an increased risk of death in hospitalized COVID-19 patients, a large study published on Friday showed.

In the study https://www.thelancet.com/lancet/article/s0140673620311806 that looked at more than 96,000 people hospitalized with COVID-19, the respiratory disease caused by the novel coronavirus, those treated with hydroxychloroquine or the related chloroquine had higher risk of death and heart rhythm problems than patients who were not given the medicines.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In World

North Korea conducts cruise missile warhead test on Friday, KCNA says
Haiti's death toll rises as international support lags, UN report says
UN warns 800,000 people in Sudan city in 'extreme, immediate danger'
Spain's Ebro-EV Motors, China's Chery join hands to develop new cars
U.S. stocks close mixed
More Ghanaians fall in love with Chinese language
Crude futures settle higher
U.S. dollar ticks up
Man sets himself on fire in New York outside Trump criminal trial court
China Focus: Major finds at Wuwangdun illuminate China's Warring States period

Others Also Read